• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术医生的专业领域对卵巢癌患者生存率的影响。

The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma.

作者信息

Kehoe S, Powell J, Wilson S, Woodman C

机构信息

Department of Obstetrics & Gynaecology, City Hospital, Birmingham, UK.

出版信息

Br J Cancer. 1994 Nov;70(5):1014-7. doi: 10.1038/bjc.1994.440.

DOI:10.1038/bjc.1994.440
PMID:7947077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2033561/
Abstract

A retrospective analysis of ovarian cancer patients registered with the West Midlands Cancer Registry from 1 January 1985 to 31 December 1987 was undertaken to examine the variables associated with survival patterns, with particular reference to the specialty of the surgeon. A total of 1,654 patients were registered, of whom 1,184 had histologically confirmed ovarian cancer, with the operator identified. This consisted of 870 patients operated on by gynaecologists and 314 operated on by general surgeons. A significantly older population and a greater number of patients with stage III/IV disease were operated on by general surgeons. The median survival of patients under the general surgeons' care was 9.87 months, significantly lower (P < 0.0001) than the survival of the gynaecologists' patients (median survival = 29.1 months). Univariate and multivariate analysis correlated poor prognosis with advanced stage disease, older age, the presence of bulky residual tumour and a general surgeon as the operator. Stepwise Cox's proportional hazard analysis confirmed the general surgeon as an independent adverse prognostic factor with a relative hazard ratio of 1.34 (95% confidence interval = 1.05-1.71). Accepting the limitations of retrospective reviews, these findings suggest that every attempt be made to ensure that a gynaecologist is involved in the treatment of patients with ovarian pathology.

摘要

对1985年1月1日至1987年12月31日在西米德兰兹癌症登记处登记的卵巢癌患者进行了回顾性分析,以研究与生存模式相关的变量,特别提及外科医生的专业。总共登记了1654名患者,其中1184名经组织学确诊为卵巢癌,且已确定手术医生。这包括870名由妇科医生进行手术的患者和314名由普通外科医生进行手术的患者。普通外科医生所治疗的患者群体年龄显著更大,且III/IV期疾病患者数量更多。普通外科医生治疗的患者中位生存期为9.87个月,显著低于(P < 0.0001)妇科医生治疗患者的生存期(中位生存期 = 29.1个月)。单因素和多因素分析表明,预后不良与疾病晚期、年龄较大、存在大量残留肿瘤以及手术医生为普通外科医生有关。逐步Cox比例风险分析证实普通外科医生是一个独立的不良预后因素,相对风险比为1.34(95%置信区间 = 1.05 - 1.71)。尽管认识到回顾性研究的局限性,但这些发现表明应尽一切努力确保妇科医生参与卵巢疾病患者的治疗。

相似文献

1
The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma.手术医生的专业领域对卵巢癌患者生存率的影响。
Br J Cancer. 1994 Nov;70(5):1014-7. doi: 10.1038/bjc.1994.440.
2
Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.妇科专家与卵巢癌的生存结局:一项对1866名患者的苏格兰全国性研究。
Br J Obstet Gynaecol. 1999 Nov;106(11):1130-6. doi: 10.1111/j.1471-0528.1999.tb08137.x.
3
What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer?癌症服务组织的哪些变革将改善卵巢癌女性患者的治疗结果?
Br J Obstet Gynaecol. 1997 Feb;104(2):135-9. doi: 10.1111/j.1471-0528.1997.tb11032.x.
4
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.外科医生专业对卵巢癌患者护理过程及结局的影响。
J Natl Cancer Inst. 2006 Feb 1;98(3):172-80. doi: 10.1093/jnci/djj019.
5
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.手术细胞减灭术对IV期上皮性卵巢癌生存的影响。
Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145.
6
Cytoreductive surgery for stage IV epithelial ovarian cancer.IV期上皮性卵巢癌的细胞减灭术。
J Exp Clin Cancer Res. 1999 Dec;18(4):449-54.
7
Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.IV期上皮性卵巢癌的预后因素:一项多中心回顾性研究。
Gynecol Oncol. 2001 Jun;81(3):398-403. doi: 10.1006/gyno.2001.6172.
8
Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998.英格兰西南部III期和IV期卵巢癌:1998年治疗病例的五年结局分析
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:25-9. doi: 10.1111/j.1525-1438.2006.00318.x.
9
Surgical outcomes in women with ovarian cancer.卵巢癌女性的手术结果。
Can J Surg. 2008 Oct;51(5):346-54.
10
Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.荷兰卵巢癌患者的专科护理与生存情况:全国队列研究
J Natl Cancer Inst. 2008 Mar 19;100(6):399-406. doi: 10.1093/jnci/djn033. Epub 2008 Mar 11.

引用本文的文献

1
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced epithelial ovarian cancer.晚期上皮性卵巢癌初始治疗中,术前新辅助化疗与手术加化疗的比较。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub7.
2
Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.新辅助化疗在手术前与手术后化疗用于晚期卵巢上皮癌的初始治疗。
Cochrane Database Syst Rev. 2021 Jul 30;7(7):CD005343. doi: 10.1002/14651858.CD005343.pub6.
3
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.晚期卵巢上皮癌初始治疗中化疗与手术的比较
Cochrane Database Syst Rev. 2021 Feb 5;2(2):CD005343. doi: 10.1002/14651858.CD005343.pub5.
4
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.晚期卵巢上皮癌初始治疗中化疗与手术的比较
Cochrane Database Syst Rev. 2019 Oct 31;2019(10):CD005343. doi: 10.1002/14651858.CD005343.pub4.
5
Differences in the outcomes of adjuvant chemotherapy for colon cancer prescribed by physicians in different disciplines: a population-based study in Taiwan.不同学科医生所开结肠癌辅助化疗方案的疗效差异:台湾一项基于人群的研究
BMJ Open. 2018 Dec 18;8(12):e021341. doi: 10.1136/bmjopen-2017-021341.
6
Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.妇科肿瘤学家参与卵巢癌护理标准的接受情况及生存情况。
World J Obstet Gynecol. 2016;5(2):187-196. doi: 10.5317/wjog.v5.i2.187. Epub 2016 May 10.
7
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.手术治疗晚期妇科和胃肠道癌症恶性肠梗阻的症状缓解。
Cochrane Database Syst Rev. 2016 Jan 4;2016(1):CD002764. doi: 10.1002/14651858.CD002764.pub2.
8
Risk of malignancy index is not sensitive in detecting non-epithelial ovarian cancer and borderline ovarian tumor.恶性风险指数在检测非上皮性卵巢癌和卵巢交界性肿瘤方面并不敏感。
J Turk Ger Gynecol Assoc. 2010 Mar 1;11(1):22-6. eCollection 2010.
9
Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States.美国卵巢癌患者接受妇科肿瘤学家治疗的差异。
Health Serv Res. 2013 Jun;48(3):1135-53. doi: 10.1111/1475-6773.12012. Epub 2012 Dec 3.
10
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.晚期卵巢上皮癌初始治疗中化疗与手术的比较
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD005343. doi: 10.1002/14651858.CD005343.pub3.

本文引用的文献

1
Treatment of advanced ovarian carcinoma in the elderly.老年晚期卵巢癌的治疗
Gynecol Oncol. 1993 Apr;49(1):86-91. doi: 10.1006/gyno.1993.1091.
2
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study.在一项针对III期(次优)和IV期卵巢癌的顺铂-环磷酰胺与卡铂-环磷酰胺的III期研究中,分析患者年龄作为生存独立预后因素的情况。西南肿瘤学组的一项研究。
Cancer. 1993 Jan 15;71(2 Suppl):618-27. doi: 10.1002/cncr.2820710220.
3
National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival.卵巢癌全国性调查。第五部分。医生专业对患者生存的影响。
Cancer. 1993 Dec 15;72(12):3663-70. doi: 10.1002/1097-0142(19931215)72:12<3663::aid-cncr2820721218>3.0.co;2-s.
4
Ovarian carcinoma--a 10-year series from a provincial hospital.卵巢癌——一家省级医院的10年病例系列研究
Acta Obstet Gynecol Scand. 1973;52(2):103-8. doi: 10.3109/00016347309158297.
5
Effect of surgical experience on the results of resection for oesophageal carcinoma.手术经验对食管癌切除结果的影响。
Br J Surg. 1986 Aug;73(8):621-3. doi: 10.1002/bjs.1800730811.
6
Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment.膀胱癌患者的生存率、治疗延迟评估、外科医生类型及治疗方式。
BMJ. 1991 Aug 24;303(6800):437-40. doi: 10.1136/bmj.303.6800.437.
7
Prognostic factors for overall survival in patients with advanced ovarian carcinoma.晚期卵巢癌患者总生存的预后因素
Ann Oncol. 1991 Apr;2(4):281-7. doi: 10.1093/oxfordjournals.annonc.a057937.
8
Ovarian cancer staging: does it require a gynecologic oncologist?卵巢癌分期:是否需要妇科肿瘤学家?
Gynecol Oncol. 1992 Nov;47(2):223-7. doi: 10.1016/0090-8258(92)90110-5.
9
The impact of subspecialty training on the management of advanced ovarian cancer.亚专业培训对晚期卵巢癌管理的影响。
Gynecol Oncol. 1992 Nov;47(2):203-9. doi: 10.1016/0090-8258(92)90107-t.